Who makes Naltrexone and Clonidine Combination?

Naltrexone and Clonidine Combination is developed by Annette C. Toledano MD.

What development phase is Naltrexone and Clonidine Combination in?

Naltrexone and Clonidine Combination is in Phase 2.

Last reviewed 2026-05-15 · How we verify

Naltrexone and Clonidine Combination

Annette C. Toledano MD · Phase 2 active Small molecule

At a glance

Generic name	Naltrexone and Clonidine Combination
Also known as	ATNC05
Sponsor	Annette C. Toledano MD
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Naltrexone and Clonidine Combination (ATNC05) in the Treatment of Chronic Back Pain (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Naltrexone and Clonidine Combination CI brief — competitive landscape report
Naltrexone and Clonidine Combination updates RSS · CI watch RSS
Annette C. Toledano MD portfolio CI